Unknown

Dataset Information

Anastrozole increases predicted adult height of short adolescent males treated with growth hormone: a randomized, placebo-controlled, multicenter trial for one to three years.


ABSTRACT:

Context

The process of epiphyseal fusion during puberty is regulated by estrogen, even in males.

Objective

Our objective was to investigate whether anastrozole, a potent aromatase inhibitor, could delay bone age acceleration and increase predicted adult height in adolescent boys with GH deficiency.

Methods

Fifty-two adolescent males with GH deficiency treated with GH were randomized to cotreatment with anastrozole or placebo daily for up to 36 months.

Results

Fifty subjects completed 12 months, 41 completed 24 months, and 28 completed 36 months. Linear growth was comparable between groups; however, there was a significantly slower increase in bone age advancement from baseline in the anastrozole group vs. placebo group after 2 yr (+1.8+/-0.1 vs. +2.7+/-0.1 yr,

SUBMITTER: Mauras N 

PROVIDER: S-EPMC2266949 | biostudies-literature | 2008 Mar

REPOSITORIES: biostudies-literature